Hydrogen Sulfide-releasing anti-inflammatory drug ATB-340 treatment potentially reduces mesenteric metaflammation in the experimental age- and high fructose dietary-induced injury / Revenko O., Kovalyshyn V., Yashchenko A., Wallace J. L., Zayachkivska O. (2021)
UkrainianEnglish

 

Institute of Information Technologies of VNLU


+38 (044) 525-36-24
Ukraine, 03039, Kyiv, Holosiivskyi Ave, 3, room 209